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Aims: If human papillomavirus (HPV) testing is to be included within cervical screening programmes, the
importance of multiple HPV infections in cervical neoplasia needs to be determined. This study investigated
the diversity of multiple HPV types in a routine cervical screening population, and assessed associations
with cervical neoplasia.
Methods: Overall HPV prevalence, type specific prevalence, and extent of multiple infection were assessed
in residual material from 3444 liquid based cytology samples, using real time GP5+/GP6+ polymerase
chain reaction for screening and linear array assay for genotyping. HPV status was studied in relation to
age and concurrent cytological evidence of dyskaryosis.
Results: Twenty per cent of samples were HPV positive. HPV type diversity was broad, and multiple HPV
infections occurred in half of the HPV positive samples. Younger women were significantly more likely to
harbour multiple high risk HPV (HR-HPV) infections. Infections with multiple HR-HPV types were found in
3.4% of samples negative for neoplasia and in 33.3%, 41.8%, and 40.4% of samples with borderline,
mild, or high grade dyskaryosis, respectively. Single HR-HPV infections were found in 4.9%, 38.6%,
45.0%, and 51.1% of negative, borderline, mild, or high grade dyskaryosis samples, respectively.
Conclusions: Multiple HR-HPV infections were most prevalent in young women. Multiple HR-HPV infections
were not more frequent in high grade than in low grade cervical neoplasia, reflecting common sexual
transmission of multiple HR-HPV. Prospective cohort studies linking sequential loss or gain of HPV types
with cytological analysis are required to assess the impact of multiple HR-HPV infections on neoplastic
progression.
T
he implementation of cytology based cervical screening
programmes has reduced the incidence of cervical
carcinoma world wide. Consequently, the development
of improved cytological preparation methods such as liquid
based cytology (LBC) and thin layer slide preparation has
been welcomed. The addition of high risk human papilloma-
virus (HR-HPV) testing may further enhance the accuracy of
screening programmes. Accumulating evidence suggests that
detection of persistent infection with the same HR-HPV type
would highlight individuals at greater risk of disease
progression,1 2 yet the extent and importance of multiple
HR-HPV infections in the progression of cervical neoplasia
and its management remain unknown. To investigate these
issues it is necessary to use genotyping methods that can
track the persistence of specific HPV types and detect
infections with multiple HR-HPV types.
‘‘Accumulating evidence suggests that detection of persis-
tent infection with the same high risk human papilloma-
virus (HR-HPV) type would highlight individuals at greater
risk of disease progression, yet the extent and importance
of multiple HR-HPV infections in the progression of cervical
neoplasia and its management remain unknown’’
A recent directive issued by the Scottish Executive has
promoted the roll out of cervical LBC for use throughout
primary care in Scotland. The residual material from LBC
specimens is an ideal template for HPV testing. We have
investigated the prevalence and diversity of HPV infection in
a routine cervical screening population in Scotland using
residual material from LBC specimens. The extent of multiple
HPV infections was assessed and compared with cytological
assessment of neoplasia. The results constitute the baseline
data of a longitudinal study designed to investigate the
impact of HPV detection, multiple HPV infection, and HPV
type specific persistence on progression of cervical neoplasia.
MATERIALS AND METHODS
Sample collection and subjects
LBC has been in place since 1999 for 15 primary care practices
in Edinburgh and, to date, over 23 000 specimens have been
received. The technique differs from the traditional Pap
smear in that after the cervical sample is taken, rather than
being deposited on a glass slide, it is rinsed into a vial
containing an alcohol based cytological preservative solution.
A small volume of the resulting cellular suspension is then
processed by a robotic device to produce a flat layer slide. The
technique has been claimed to enhance the accuracy of
cytological assessment. It also has the advantage that the
residual suspension, not used for cytology, can act as a
template for microbiological testing. Local research ethics
committee approval was granted for microbiological testing
and informed consent was obtained. In 2000, we chose a
subset of 3444 randomly selected specimens (age range, 16.5–
78 years; mean age, 36.6) to determine HPV prevalence.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: HIV, human immunodeficiency virus; HPV, human
papillomavirus; HR, high risk; LBC, liquid based cytology; LA, linear
array; LR, low risk; PCR, polymerase chain reaction
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Primary care personnel performed specimen collection, flat
layer slides were created by the ThinPrepH procedure, and
cytological grading was performed according to British
Society for Clinical Cytology guidelines. After cytology,
residual cells in the specimens were centrifuged at 2800 6g
for 10 minutes and stored as cellular pellets at 270 C˚ in a
lysis buffer (Qiagen Ltd, Crawley, West Sussex, UK) before
nucleic acid extraction and HPV detection.
HPV detection and genotyping
Briefly, automated nucleic acid extraction of cellular pellets
was performed on a BioRobot 9604H (Qiagen Ltd) using the
96 well silica column plates and reagents supplied within the
QIAampH 96 DNA Swab BioRobot kit. The robotic protocol,
which is optimised for LBC samples, was carried out as
described previously.3 HPV detection was performed by real
time polymerase chain reaction (PCR) using GP5+/GP6+
consensus PCR primers with the LightCyclerTM apparatus, as
described previously.4 Genotyping of HPV positive samples
was performed via linear array (LA) hybridisation assay,5 6
which involved the hybridisation of PCR products to a strip
containing two levels of b globin control probes, 18 HR-HPV
probes (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 55, 56, 58, 59, 68,
73, 82, 83), and nine low risk HPV (LR-HPV) probes (6, 11,
40, 42, 53, 54, 57, 66, 84) (E McGoogan, unpublished data,
2003).6 An HPV type was described as ‘‘type X’’ if a sample
was positive by real time PCR yet negative by the LA assay.
Prevalence measurements
Women were stratified according to their concurrent cervical
cytology grade, age, detection of LR-HPV or HR-HPV type(s),
and presence of multiple HPV infections. The proportion of
multiple HR-HPV infections was assessed in relation to the
severity of cervical neoplasia and compared with data from
patients harbouring a single HR-HPV type. HPV genotypes
were ranked according to the frequency of detection in all
positive samples, and then according to their frequency in
cytologically negative, borderline dyskaryosis, mild dyskaryo-
sis, and high grade dyskaryosis samples. Samples classified as
having high grade dyskaryosis displayed either moderate or
severe dyskaryosis, or evidence of suspected invasion.
Statistical analysis of data
When determining the prevalence of HR-HPV and LR-HPV
types, women were counted more than once if they
harboured a multiple infection with a mixture of both. The
prevalence of individual HPV types was determined as they
appeared as either single or within multiple infections.
Multiple HPV infection was defined as two or more HPV
types detected. Multiple HR-HPV infection was defined as
two or more HR-HPV types, with or without additional LR-
HPV types. To examine the relation between HPV infection
and the severity of cytological grade of cervical neoplasia, and
to assess whether the difference in age between HPV positive
and negative groups was significant, x2 tests for linear trend
and Mann-Whitney U tests were performed. The strength of
association of multiple HR-HPV infections, as opposed to
single HR-HPV infection, with cytological grade of cervical
neoplasia was analysed by a x2 test. All statistics were
performed using SPSS v11 software.
RESULTS
Cytological analysis of cervical samples
Of the 3444 cervical samples analysed by HPV testing and
cytological assessment of dyskaryosis, approximately 10%
exhibited some degree of cytological neoplastic abnormality,
including 3.3% borderline dyskaryosis, 3.7% mild dyskaryo-
sis, and 2.7% high grade dyskaryosis. Only 0.5% of samples
were graded unsatisfactory for cytological assessment
(table 1).
HPV prevalence
HPV DNA was detected in 705 of 3444 samples tested (20%).
Of the HPV positive samples, 114 (16%) were classified as
type X. Thus, distribution trends of HR-HPV and LR-HPV
types within the population were drawn from the remaining
591 that could be identified by the LA assay. Eligibility of the
samples for HPV testing was confirmed by positive b globin
results.
As detailed in table 1, overall, HR-HPV types were more
prevalent than LR-HPV types, even in individuals who had no
cervical neoplasia detected. LR-HPV and HR-HPV types were
detected in 187 (26.5%) and 540 (76.6%) of all 705 HPV
positive individuals, respectively (representing 5.5% and
15.7% of the overall population of 3444, respectively). LR-
HPV types were detected in only 10 of 94 (10.6%) of those
with high grade dyskaryosis, always as part of a mixed
infection with at least one other HR-HPV type. No exclusively
LR-HPV infections were found in those with high grade
dyskaryosis. The prevalence of unknown/untypable HPV
Table 1 Prevalence of HPV in Edinburgh and Lothian’s routine cervical screening population
Prevalence of HPV
No. tested
(% population )
HPV +ve
(%)
HPV –ve
(%)
HR-HPV +ve
(%)
HR-HPV +ve only
(%)
LR-HPV +ve
(%)
LR-HPV +ve
only (%)
Unknown HPV
type (%)
Dyskaryosis
Negative 3089 (89.7) 392 (12.7) 2697 (87.3) 257 (8.3) 200 (6.5) 93 (3.0) 36 (1.2) 99 (3.2)
Borderline 114 (3.3) 97 (85.1) 17 (14.9) 82 (71.9) 53 (46.5) 38 (33.3) 9 (7.9) 6 (5.3)
Mild 129 (3.7) 124 (96.1) 5 (3.9) 112 (86.8) 72 (55.8) 46 (35.7) 6 (4.6) 6 (4.6)
High grade 94 (2.7) 88 (93.6) 6 (6.4) 86 (91.5) 76 (80.8) 10 (10.6) 0 2 (2.1)
U/S 18 (0.5) 4 (22.2) 14 (77.8) 3 (16.6) 3 (16.6) 0 0 1 (5.5)
Age
,25 734 (21.3) 308 (42.0) 426 (58.0) 260 (35.4) 171 (23.3) 111 (15.1) 22 (2.9) 26 (3.5)
25–35 935 (27.2) 211 (22.6) 724 (77.4) 158 (17.0) 127 (13.6) 44 (4.7) 13 (1.34) 40 (4.3)
35–45 893 (25.9) 116 (13.0) 777 (87.0) 80 (9.1) 69 (7.7) 20 (2.2) 9 (1.0) 27 (3.0)
45–55 603 (17.5) 55 (9.1) 548 (90.9) 33 (5.5) 29 (4.8) 8 (1.3) 4 (0.7) 18 (3.0)
.55 279 (8.1) 15 (5.4) 264 (94.6) 9 (3.2) 8 (2.9) 4 (1.4) 3 (1.1) 3 (1.1)
Total 3444 705 2739 540 404 187 51 114
HPV +ve, all who tested HPV DNA positive (includes any individual who tested positive for HR-HPV and or LR-HPV type(s), in addition to those who were positive by
PCR but untypable by the LA assay). HPV –ve, all who did not test HPV DNA positive. HR-HPV +ve, all who tested positive for at least 1 HR-HPV type (mixed
infections with low risk types are included). HR-HPV +ve only, all who tested positive for a HR-HPV type or types only. LR-HPV +ve, all who tested positive for at least
1 LR-HPV type (mixed infections with high risk types are included). LR-HPV +ve only, all who tested positive for a LR-HPV type or types only. Unknown HPV type, all
who tested positive for HPV using real time PCR but hybridised to none of the 27 probes in the LA assay.
HPV, human papillomavirus; HR, high risk; LA, linear array; LR, low risk; PCR, polymerase chain reaction; U/S, unsatisfactory.
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infections when assessed separately from HR-HPV infections
did not correlate with age or cytological status (table 1).
With increasing severity of cytological grade of dyskaryosis,
there was an increasing prevalence of HR-HPV (p , 0.001),
with HR-HPV detected in 86 of 94 (91.5%) of those with high
grade dyskaryosis, compared with 112 of 129 (86.8%) of
mildly dyskaryotic and 82 of 114 (71.9%) of borderline
dyskaryotic samples (table 1). When LR-HPV and unknown
HPV types were included in the HPV positive group, there
was an association between the presence of HPV (‘‘any’’ type)
and evidence of dyskaryosis. Detection of HPV decreased with
increasing age, with the highest prevalence (either HR-HPV,
or LR-HPV, or ‘‘any’’ HPV) being found in women , 25
years. The median ages of those who tested HPV positive
(26.610 years) and negative (37.490 years) were significantly
different (p , 0.001)
Multiple HPV infections
The prevalence of multiple HPV infections in this population
was high, with 43.3% of samples that were HPV positive
hybridising to more than one HPV type on the LA assay
(table 2; fig 1). The most common type of multiple HPV
infection was HR-HPV types only (table 3), with 164 of 705
(23.3%) (705 being the total number of HPV positive
infections detected overall) falling within this category. HR-
HPV and LR-HPV types were found together in 136 of 705
(19.3%), whereas exclusively LR-HPV multiple infections
were only detected in six of 705 (0.8%). Infections with
multiple HR-HPV types were found in 105 of 3089 (3.4%)
samples negative for neoplasia, and in 38 of 114 (33.3%), 54
of 129 (41.8%), and 38 of 94 (40.4%) samples with border-
line, mild, or high grade dyskaryosis. There was no increased
association (by x2 test) between multiple HR-HPV infection
and severity of neoplasia when compared with single HR-
HPV infections, which were identified in 152 (4.9%) of
negative samples, but in 44 (38.6%), 58 (45.0%), and 48
(51.1%) patients with borderline, mild, or high grade
dyskaryosis, respectively. Just under half of the HR-HPV
infections were positive for more than one HR-HPV type
across all cytological grades of dyskaryosis (fig 1). The
prevalence of multiple HPV (all types) infections and multi-
ple HR-HPV infections was also found to decrease with
increasing age (p , 0.001) (table 2).
HPV type specific detection
A broad diversity of infecting HR-HPV types was revealed
with every HR-HPV type on the LA assay detected (table 4).
Overall, the most abundant HR-HPV types were
16 . 18 . 51 . 31 . 52, with HPV-16 detectable in 222 of
705 (31.5%) HPV positive individuals, constituting a pre-
valence of 6.4% of the overall population. In contrast, HPV
types 18, 51, 31, and 52 were detected in smaller proportions
of samples, ranging from 2.2% to 1.8% of the overall
population. When HR-HPV type specific infection was
stratified by cytological grade of dyskaryosis, HPV-16
exhibited prevalences of 105 of 3089 (3.4%), 69 of 243
(28.0%), and 46 of 94 (48.9%) within samples with negative,
low grade (borderline and mild dyskaryosis samples com-
bined), and high grade dyskaryosis, respectively, whereas
HPV-18 showed prevalences of 1.4%, 9.5%, and 11.7% for
these three groups. HPV-31 was the second most prevalent
HR-HPV type in high grade dyskaryosis (17 of 94; 18.0%).
Interestingly, HPV-73 was found in 10.6% of high grade, but
in only 5.8% of low grade dyskaryosis samples (table 3).
DISCUSSION
Because of the very low percentage (0.5%) of cytologically
unsatisfactory reports in this population, this work lends
support to the use of LBC for cervical screening. Additional
work on grading 17 880 LBC samples collected from the same
cervical screening population revealed only 0.6% as unsatis-
factory, in contrast to 10% unsatisfactory samples when 8670
conventional Pap smears from the previous year were
assessed (E McGoogan, unpublished data, 2003). These data
imply that LBC screening can lead to reduced primary care
Table 2 Prevalence of multiple HPV infections according
to cytological grade of dyskaryosis and age
Multiple HPV
infection
Total single
HR-HPV +ve
Total multiple
HR-HPV +ve
Dyskaryosis
Negative 139 (4.5) 152 (5.0) 105 (3.4)
Borderline 50 (43.8) 44 (38.6) 38 (33.3)
Mild 73 (56.6) 58 (44.9) 54 (41.8)
High grade 43 (45.7) 48 (51.1) 38 (40.4)
U/S 1 (5.5) 2 1 (5.5)
Age
,25 186 (25.3) 113 (15.4) 147 (20.0)
25–35 78 (8.3) 97 (10.4) 61 (6.5)
35–45 28 (3.1) 61 (6.8) 19 (2.1)
45–55 11 (1.8) 26 (4.3) 7 (1.2)
.55 3 (1.1) 7 (2.5) 2 (0.7)
Total 306 304 236
Values are numbers of samples and percentages in parenthesis. Mutiple
HPV infection, sample tested positive for .1 HPV type by LA assay. Total
single HR-HPV +ve, sample tested positive for a single HR-HPV infection,
either alone or with other LR-HPV types present. Total multiple HR-HPV
+ve, samples tested positive for .1 HR-HPV type (sample could have
contained LR-HPV types also).
HPV, human papillomavirus; HR, high risk; LA, linear array; LR, low risk;
U/S, unsatisfactory.
Figure 1 Prevalence of single and multiple high risk human
papillomavirus (HR-HPV) infections associated with concurrent
cytological grade of dyskaryosis. Neg, negative for dyskaryosis; Bord,
borderline dyskaryosis; Mild, mild dyskaryosis; High grade, moderate or
severe dyskaryosis or suspected invasion.
Table 3 Distribution of multiple infection containing HR-
HPV types exclusively, LR and HR-HPV types, and LR-HPV
types exclusively
HR-HPV only
HR-HPV and
LR-HPV LR-HPV only
Dyskaryosis
Negative 77 (2.5) 57 (1.8) 5 (0.2)
Borderline 20 (17.5) 29 (25.4) 1 (0.9)
Mild 33 (25.6) 40 (31.0) 0
High grade 33 (35.1) 10 (10.6) 0
U/S 1 (5.5) 0 0
Age
,25 93 (12.7) 89 (12.1) 4 (0.5)
25–35 46 (4.9) 31 (3.3) 1 (0.1)
35–45 17 (1.9) 11 (1.2) 0
45–55 6 (1.0) 4 (0.6) 1 (0.2)
.55 2 (0.7) 1 (0.3) 0
Total 164 136 6
Values are numbers of samples and percentages in parenthesis.
HPV, human papillomavirus; HR, high risk; LR, low risk; U/S,
unsatisfactory.
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costs and a reduction in patient anxiety.7 The efficient
turnaround time of LBC testing, coupled with application of
the high throughput nucleic extraction system, as performed
in our study, confirms the practicality of HPV testing in a
routine setting.
From a global perspective, Edinburgh comprises a stable,
largely white population with a low incidence of cervical
cancer, estimated at 4.3 deaths/100 000. However, the overall
prevalence of all HPV types in the population was quite high
(20%) and is close to that detected in ‘‘high risk’’ populations
such as Colombia (14.9%) and Paraguay (20%).8 9 However,
estimates of HPV prevalence vary considerably, as shown in a
USA study where 39.2% of 3863 women aged 18–40
attending a routine gynaecological clinic were HPV positive.10
The apparent disparity in prevalences strengthens the case for
epidemiological evaluation on a population by population
basis.
As with HR-HPV prevalence, LR-HPV prevalence was
significantly higher in younger women, who usually have
higher levels of sexual activity.11 12 A second peak of HPV
prevalence in peri-menopausal women was not evident in
this population (as has been described previously,13 14) and
contrary to the findings of Chan et al,15 most HPV infections
in this age group were not LR-HPV.
HR-HPV types were detected more frequently than LR-HPV
types in women of all ages and grades of dyskaryosis. The
diversity of HPV types was broad, and approximately 9.3% of
the population tested positive for an HR-HPV type other than
HPV-16 (found in 6.4% of the population). Most of these
infections were found in younger women and many are likely
to be cleared. Yet, even in HPV positive women with high
grade neoplasia, over 50% contained an HPV type or types
other than HPV-16. More specifically, 29 of 1775 (1.6%)
women who were over 35 years within our study exhibited
high grade neoplasia. Of these, 12 were infected with HPV-
16, 14 had an HR-HPV type or types other than HPV-16, and
three were infected with type X, confirming a high prevalence
and diversity of oncogenic HPV types.
‘‘We found that HPV-26, previously described as prob-
ably carcinogenic, was the only type to be detected
exclusively in cytologically abnormal samples, thereby
supporting this classification’’
Unexpectedly, HPV-31 was found more commonly than
HPV-18 in high grade dyskaryosis. HPV-73 was found in a
similar proportion to HPV-18 in high grade neoplasia,
consolidating its ‘‘high risk’’ status, as described in a recent
article by Mun˜oz et al.16 In addition, we found that HPV-26,
previously described as ‘‘probably carcinogenic’’,16 was the
only type to be detected exclusively in cytologically abnormal
samples, thereby supporting this classification. If HPV testing
is to become incorporated into screening programmes, a
broad spectrum test should be implemented until the true
impact of the persistence of less common HR-HPV types in
neoplastic progression is established.
The most striking feature that we noted was the high
prevalence of multiple HR-HPV infections in all grades of
cervical neoplasia. Currently, there is a lack of consensus
within the literature about the extent and implications of
multiple HPV infections, with reported prevalences varying
from 17.5% in a gynaecological referral clinic population,10 to
46% in cancer biopsies,17 and 58.9% in women with low grade
dysplasia.18 Human immunodeficiency virus (HIV) positive
individuals are often infected with multiple HPVs, with
reported figures of up to 80%.19 Indeed, the detection of
multiple HPV infections has been proposed by one group as a
prognostic indicator for high grade neoplasia in HIV infected
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women (U Weiland et al. Genital infections with multiple
HPV types are frequent, are more associated with SIL and are
more prevalent in HIV positive patients. Abstracts of the 20th
International Papillomavirus Conference, Paris, France,
2002:75). In addition, in a study of immunocompetent
women, multiple HPV infections were found to confer an
increased odds ratio for risk of dysplasia that was second only
to HPV-16 positivity.20 Significant differences in the mean
number of HPV types detected between cytologically normal
and dysplastic samples has also been reported.21 In contrast,
Rolo´n et al found no significantly higher risk of carcinoma in
women with multiple HPV infections compared with those
who were infected with a single HPV type.9
‘‘The key finding here of a high prevalence of multiple
high risk human papillomavirus (HR-HPV) types in all
grades of cervical neoplasia emphasises the lack of a
cooperative carcinogenic relation between particular pairs
or groups of HR-HPV types’’
Cross sectional analysis of our data indicated that the
detection of multiple HPV infections with HR-HPV types was
not a significantly better predictor of high grade cervical
neoplasia than single HR-HPV infection. Furthermore, multi-
ple HR-HPV infections were more frequently found in
younger women, who are more likely to be infected with
HPV per se, suggesting that greater sexual activity is
associated with sexual transmission of multiple HR-HPV
types, perhaps more commonly than was previously thought.
Thomas et al showed that no two HPV types were more or less
likely to be acquired concurrently than any other two types.22
Rousseau et al suggested that persistence of HPV infection
may be independent of coinfection with multiple HPV types
at baseline,23 and Chaouki et al suggested that different HPV
types did not act cooperatively in neoplastic transformation.24
Therefore, the key finding here of a high prevalence of
multiple HR-HPV types in all grades of cervical neoplasia
emphasises the lack of a cooperative carcinogenic relation
between particular pairs or groups of HR-HPV types. This
finding probably reflects the common sexual transmission of
multiple HR-HPV types together. We hope the second phase
of our longitudinal study will further address the relevance of
multiple HR-HPV infections on the progression of cervical
neoplasia.
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Take home messages
N There was a high prevalence of multiple high risk
human papillomavirus (HR-HPV) infections in both high
grade and low grade cervical neoplasia, reflecting
common sexual transmission of multiple HR-HPV
N Multiple HR-HPV infections were most prevalent in
young women, suggesting that greater sexual activity is
associated with sexual transmission of multiple HR-HPV
types
N Prospective cohort studies that link sequential loss or
gain of HPV types with cytological analysis are
required to assess the impact of multiple HR-HPV
infections on neoplastic progression
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